References
- Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis. Circulation. 2018;138(11):1100–1112. DOI: 10.1161/CIRCULATIONAHA.117.033369
- Ogugu EG, Bidwell JT, Ruark A, Butterfield RM, Weiser SD, Neilands TB, et al. Barriers to accessing care for cardiometabolic disorders in Malawi: partners as a source of resilience for people living with HIV. Int J Equity Health. 2024;23(1):83. DOI: 10.1186/s12939-024-02181-9
- Conroy AA, Bidwell JT, Ruark A, Neilands TB, Weiser SD, Butterfield RM, et al. Managing multimorbidity together: relationship dynamics and dual medication adherence for hypertension and HIV in Malawi. Ann Behav Med. 2025;59(1):kaaf052. DOI: 10.1093/abm/kaaf052
- Goff DC
Jr. , Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RBSr. , Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2935–2959. DOI: 10.1161/01.cir.0000437741.48606.98 - Gowshall M, Taylor-Robinson SD. The increasing prevalence of non-communicable diseases in low-middle income countries: the view from Malawi. Int J Gen Med. 2018;11:255–264. DOI: 10.2147/IJGM.S157987
- WHO. Global action plan for the prevention and control of noncommunicable diseases 2013–2020. World Health Organization; 2013.
- Ogugu E, Bidwell J, Butterfield R, Ruark A, Neilands T, Weiser S, et al. Abstract 4143505: an examination of contextual and self-management factors in relation to blood pressure control among adults managing comorbid HIV and hypertension in Malawi. Circulation. 2024;150(Suppl_1):A4143505–A4143505. DOI: 10.1161/circ.150.suppl_1.4143505
- Wu J, Chen D, Li C, Wang Y. Agreement between self-reported and objectively measured hypertension diagnosis and control: evidence from a nationally representative sample of community-dwelling middle-aged and older adults in China. Arch Public Health. 2024;82(1):245. DOI: 10.1186/s13690-024-01456-5
- Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5(2):74–79. DOI: 10.1310/JFXH-G3X2-EYM6-D6UG
- Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. Aids. 2002;16(2):269–277. DOI: 10.1097/00002030-200201250-00017
- R Core Team. R version 4.4.2. 2024.
- McHugh ML.
Interrater reliability: the kappa statistic . Biochem Med (Zagreb). 2012.22(3):276–282. DOI: 10.11613/BM.2012.031 - Basu S, Garg S, Sharma N, Singh MM. Improving the assessment of medication adherence: challenges and considerations with a focus on low-resource settings. Tzu Chi Med J. 2019;31(2):73–80. DOI: 10.4103/tcmj.tcmj_177_18
- Glass T, Cavassini M. Asking about adherence – from flipping the coin to strong evidence. Swiss Med Wkly. 2014;144:w14016. DOI: 10.4414/smw.2014.14016